XML 51 R30.htm IDEA: XBRL DOCUMENT v3.24.1
Taxes on Income (Tables)
12 Months Ended
Dec. 31, 2023
Taxes on Income [Abstract]  
Schedule of Company’s Loss Before Income Taxes The following are the domestic (i.e. Israeli) and foreign components of the Company’s loss before income taxes:
  

Year ended

December 31,

 
   2023   2022   2021 
             
Domestic  $(43,500)  $(40,494)  $(58,092)
Foreign   -    -    - 
Total  $(43,500)  $(40,494)  $(58,092)
Schedule of Reconciliation Income Tax Benefit The reconciliation of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company’s reported income tax (benefit) is as follows:
  

Year ended

December 31,

 
   2023   2022   2021 
Loss before income taxes, as reported in the consolidated statements of operations  $43,500   $40,494   $58,092 
Statutory tax rate   23%   23%   23%
                
Income tax benefit at statutory tax rate  $(10,005)  $(9,314)  $(13,361)
Effect of Non-deductible expenses   3,063    475    6,129 
Remeasurement of deferred taxes from currency exchange*   -    3,517    209 
Change in valuation allowance   7,508    5,322    7,023 
Other   (566)   -    - 
Reported income taxes benefit  $-   $-   $- 
*The income Tax Regulations (rules regarding ledger management of foreign invested companies and certain partnerships and the determination of their taxable income), 1986 allow Foreign Invested Companies (i.e., foreign holding percentage of more than 25%) to report for tax purposes in US dollars. The Company implemented these regulations on January 1, 2023.

 

Schedule of Deferred Tax Assets The principal components of the Company’s deferred tax assets are as follows:
   December 31 
   2023   2022 
Deferred tax assets:        
Net operating loss carry forwards  $28,032   $21,991 
Research and development   6,252    4,834 
Employees and payroll accrual   299    272 
Property and equipment   79    57 
Total deferred tax assets   34,662    27,154 
           
Valuation allowance   (34,662)   (27,154)
           
Deferred tax assets, net of valuation allowance  $-   $-